image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Mircrolise

September 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SAAS
  • Price:
  • 133p
Boosted by a full six-month contribution from the Vita acquisition and a partial contribution from ESS, Microlise’s H1 shows a 15% increase in sales to £39.1m and EBITDA rising by 17% to £5.2m, with margins expanding to 13.4%, reflecting strong growth in recurring revenue (annual  recurring revenues surged 22% to £54m). The company’s net cash stands at £8.9m. Microlise has a best in class offering in the UK that continues to cross-sell acquired and developed products whilst also expanding overseas. Microlise now serves three of Australia’s four largest supermarket chains and the two largest in New Zealand. Additionally, it’s made significant inroads in France, securing its largest customer to date, STAF, a leading player in the tr ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Microlise (May 2024)
Microlise - ARR up 11% to £47.2m (February 2024)
Microlise - Interesting new issue (September 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW